25.11 USD
-0.02 (-0.08%)
Overall CHSCN gets a fundamental rating of 3 out of 10. We evaluated CHSCN against 87 industry peers in the Food Products industry. There are concerns on the financial health of CHSCN while its profitability can be described as average. CHSCN has a expensive valuation and it also scores bad on growth. CHSCN also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHSCN had a positive cash flow from operations.
Each year in the past 5 years CHSCN has been profitable.
CHSCN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.61%, CHSCN is in line with its industry, outperforming 55.17% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.76%, CHSCN is in line with its industry, outperforming 51.72% of the companies in the same industry.
With a Return On Invested Capital value of 0.05%, CHSCN perfoms like the industry average, outperforming 40.23% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHSCN is significantly below the industry average of 28.38%.
The 3 year average ROIC (6.11%) for CHSCN is well above the current ROIC(0.05%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.61% | ||
| ROE | 4.76% | ||
| ROIC | 0.05% |
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
1.3 Margins
CHSCN has a Profit Margin of 1.42%. This is comparable to the rest of the industry: CHSCN outperforms 49.43% of its industry peers.
CHSCN's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 0.02%, CHSCN perfoms like the industry average, outperforming 40.23% of the companies in the same industry.
In the last couple of years the Operating Margin of CHSCN has declined.
Looking at the Gross Margin, with a value of 2.99%, CHSCN is doing worse than 87.36% of the companies in the same industry.
CHSCN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.02% | ||
| PM (TTM) | 1.42% | ||
| GM | 2.99% |
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHSCN is still creating some value.
CHSCN has a worse debt/assets ratio than last year.
2.2 Solvency
CHSCN has an Altman-Z score of 2.22. This is not the best score and indicates that CHSCN is in the grey zone with still only limited risk for bankruptcy at the moment.
CHSCN's Altman-Z score of 2.22 is in line compared to the rest of the industry. CHSCN outperforms 51.72% of its industry peers.
CHSCN has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CHSCN (0.34) is better than 60.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.22 |
ROIC/WACC0.01
WACC4.68%
2.3 Liquidity
A Current Ratio of 1.40 indicates that CHSCN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, CHSCN is in line with its industry, outperforming 44.83% of the companies in the same industry.
CHSCN has a Quick Ratio of 1.40. This is a bad value and indicates that CHSCN is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSCN has a Quick ratio (0.86) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
The Revenue has decreased by -8.96% in the past year.
The Revenue has been growing slightly by 4.24% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CHSCN is valued cheaper than 95.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.75 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CHSCN has a Yearly Dividend Yield of 7.06%, which is a nice return.
Compared to an average industry Dividend Yield of 5.21, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 90.80% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, CHSCN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.06% |
5.2 History
CHSCN has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
5.3 Sustainability
CHSCN pays out 32.94% of its income as dividend. This is a sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:CHSCN (11/26/2025, 8:21:54 PM)
25.11
-0.02 (-0.08%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners11.67%
Inst Owner Change1043.08%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap308.10M
Revenue(TTM)36.03B
Net Income(TTM)513.00M
Analysts0
Price TargetN/A
Short Float %0.1%
Short Ratio0.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.06% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years10
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.64 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 3.75 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY155.14%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.61% | ||
| ROE | 4.76% | ||
| ROCE | 0.07% | ||
| ROIC | 0.05% | ||
| ROICexc | 0.05% | ||
| ROICexgc | 0.05% | ||
| OM | 0.02% | ||
| PM (TTM) | 1.42% | ||
| GM | 2.99% | ||
| FCFM | N/A |
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexgc growth 3Y38.36%
ROICexgc growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 5.94 | ||
| Cap/Depr | 131.31% | ||
| Cap/Sales | 2.22% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 77.22% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.86 | ||
| Altman-Z | 2.22 |
F-Score3
WACC4.68%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%
CHS INC - CHSINC 7.1 PERP / CHSCN FAQ
What is the ChartMill fundamental rating of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCN.
Can you provide the valuation status for CHS INC - CHSINC 7.1 PERP?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 7.1 PERP (CHSCN). This can be considered as Overvalued.
What is the profitability of CHSCN stock?
CHS INC - CHSINC 7.1 PERP (CHSCN) has a profitability rating of 4 / 10.
What is the financial health of CHS INC - CHSINC 7.1 PERP (CHSCN) stock?
The financial health rating of CHS INC - CHSINC 7.1 PERP (CHSCN) is 3 / 10.